News Release
You can select the year, month, and category you wish to view.
- All
- Business Development
- Drug Discovery
- General Meeting of Shareholders
- Financial Information
- Other
-
2025.03.18
Announcement of the Conclusion of a Joint Research Agreement with the National Cancer Center
(259KB)
-
2025.03.18
Report on the Investigator Meeting for the PC-SOD Phase II Clinical Trial
(931KB)
-
2025.03.18
Announcement of PMDA face-to-face advice (consultation after completion of Phase II trials) for PC-SOD.
(179KB)
-
2025.03.18
Invited Lecture by our CEO, Tohru Mizushima, at APOPC2024
(884KB)
-
2025.03.18
Report on the JHVS (co-hosted with BioJapan 2024) exhibition
(685KB)
-
2025.03.18
Meeting between the Chairman of Beijing Tide Pharmaceutical Co., LTD. and the CEO of Sino Biopharmaceutical Co., Ltd. and our CEO
(148KB)
-
2025.03.18
Request for notification of changes to the shareholder register, such as change of address
(125KB)
-
2025.03.18
Announcement of the start of the second phase of the first clinical trial of PC-SOD
(176KB)
-
2025.03.18
Notice of Resolutions of the 22nd Ordinary General Meeting of Shareholders
(96KB)
-
2025.03.18
Announcement of a lecture by our CEO, Tohru Mizushima, at Nagasaki International University
(333KB)
